Loading organizations...
§ Venture Capital · Guangzhou, Guangdong, China
Online B2C pharmacy platform offering medicines and healthcare products for consumers, focused on direct-to-consumer sales in China.
Jianke has raised $130.0M across 1 funding round.
Key people at Jianke.
Jianke was founded in 2015 by Fangmin Xie (Founder and CEO).
Jianke has raised $130.0M in total across 1 funding round.
Jianke operates an online B2C pharmacy platform offering medicines, healthcare products, and services, based in Guangzhou, Guangdong, China. The company provides over 680,000 stock keeping units (SKUs) to a cumulative customer base exceeding 100 million, maintaining a repeat purchase rate over 50%. Jianke has raised $280 million across three funding rounds, with a valuation estimated between $500-600 million as of 2017, positioning it as China's second-largest online drug store at that time. Key investors include Crescent Point, GTJA Investment Group, and HBM Healthcare Investments, with GTJA leading a $130 million Series B round in 2018. The organization was founded in 2009 by Xie Fangmin, who also serves as its CEO and chairman. Its business model centers on E-commerce marketplace for direct-to-consumer sales of pharmaceuticals and healthcare products.
Jianke was founded in 2015 by Fangmin Xie (Founder and CEO).
Jianke has raised $130.0M in total across 1 funding round.
Jianke's investors include GTJA Investment Group, Crescent Point, HBM Healthcare Investments.
Key people at Jianke.
Jianke has raised $130.0M across 1 funding round. Most recently, it raised $130.0M Series B in September 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2019 | Biofourmis | $35.0M Series B | MassMutual Ventures, Peak XV Partners (Sequoia Capital India) | Alpha JWC Ventures, American Family Ventures, AXA Strategic Ventures, Openspace Ventures, Aviva Ventures, Swee Yeok Chu, PBM, Sginnovate |
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 4, 2018 | $130M Series B | Gtja Investment Group | Crescent Point, HBM Healthcare Investments | Announced |